Identification of Viral Variants Involved in the Transmission of Hepatitis C and Characterization of Antigenic and Functional Properties of Their Envelope Glycoproteins
NCT02574884 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 8
Last updated 2015-10-14
Summary
The study consists to Identify viral variants involved in the transmission of hepatitis C and characterize the antigenic and functional properties of their envelope glycoproteins at very early stage of infection (before seroconversion).
Conditions
- Hepatitis C
Interventions
- PROCEDURE
-
Blood sample (act specific of blood withdrawal for the study)
Specific intervention : blood sample (3x7 ml in total)
Sponsors & Collaborators
-
University Hospital, Tours
lead OTHER
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- PREVENTION
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2011-08-31
- Primary Completion
- 2013-01-31
- Completion
- 2013-07-31
Countries
- France
Study Locations
More Related Trials
-
Predictive Factors of the Treatment Failure in Hepatitis C Virus (HCV) Infected Patients Treated With Telaprevir
NCT01577069 ·Status: COMPLETED
-
Investigative Mathematical Modeling of Hospital Transmission of Hepatitis C
NCT02826447 ·Status: UNKNOWN
-
Pharmacogenomics Study on IL28B Genetic Variants in Italian Patients With HCV Infection naïve to Treatment.
NCT01437969 ·Status: COMPLETED
-
Chronic Hepatitis C (CHC) - Genotype 3 Infection in Canada
NCT01100749 ·Status: TERMINATED
-
Study Investigating Immunological Effects of Treatment for Chronic Hepatitis C Patients.
NCT00422838 ·Status: COMPLETED
-
Efficacy of PegInterferon-Ribavirin-Boceprevir Therapy in Patients Infected With G1 HCV With Cirrhosis, Awaiting Liver Transplantation
NCT01463956 ·Status: COMPLETED ·Phase: PHASE2
-
Feasibility of Implementing a Cohort of People Living With Hepatitis C in Vietnam
NCT03601546 ·Status: UNKNOWN
-
A Study of Predictors of the Effectiveness of Pegylated Interferon in a Cohort of Participants With Hepatitis C
NCT01659567 ·Status: COMPLETED
-
A Study of Ritonavir-Boosted Danoprevir (RO5190591) in Combination With Pegasys and Ribavirin in Patients With Chronic Hepatitis C Genotype 1
NCT01185860 ·Status: COMPLETED ·Phase: PHASE1
-
Chronic Hepatitis C Treatment by Pegylated Interferon and Ribavirin in Naive Egyptian Patients (ANRS 1211)
NCT00158496 ·Status: COMPLETED ·Phase: PHASE3
-
HCV Evolution in HIV/HCV (Genotype 1) Coinfected Patients Treated With Fosamprenavir
NCT01222611 ·Status: COMPLETED ·Phase: PHASE4
-
Access Anti-HCV Assay European Union (EU) Clinical Trial Protocol
NCT04971330 ·Status: COMPLETED
-
Retrieval of Hepatitis C Patients Lost to Follow-up
NCT04153708 ·Status: UNKNOWN ·Phase: NA
-
The Natural History and Treatment of Acute Hepatitis C Virus (HCV) in HIV-positive Individuals
NCT01289652 ·Status: UNKNOWN
-
Efficacy of Pegylated Interferon Alone in Egyptian Patients With Acute Hepatitis C (ANRS 1213)
NCT00158522 ·Status: COMPLETED ·Phase: PHASE3
-
Short Duration Therapy of Acute Hepatitis C Genotypes 1 or 4
NCT02886624 ·Status: COMPLETED ·Phase: PHASE2
-
The Effectiveness of Paritaprevir/Ritonavir - Ombitasvir, ± Dasabuvir, ± Ribavirin in France
NCT02618928 ·Status: COMPLETED
-
Study of Hepatic Responses in Patients Receiving Direct-acting Anti-HCV Drugs
NCT02532907 ·Status: COMPLETED
-
Impact of Interferon-free Treatment for Hepatitis C Virus (HCV) on Blood Cells and Factors in Blood
NCT02718573 ·Status: COMPLETED
-
Combination Therapy for Chronic Hepatitis C Infection
NCT01805882 ·Status: COMPLETED ·Phase: PHASE2
-
French Cohort of Therapeutic Failure and Resistances in Patients Treated With a Protease Inhibitor (Telaprevir or Boceprevir), Pegylated Interferon and Ribavirin
NCT01514890 ·Status: COMPLETED
-
Analysis of Host Genetic Factors in the Occurrence of Anemia and on the Virological Response to a Peg-interferon/Ribavirin Therapy in HIV-HCV Co-infected Patients
NCT01964742 ·Status: COMPLETED ·Phase: NA
-
Predictors of Response to Combined Pegylated Interferon and Ribavirin in Chronic Hepatitis C Infected Egyptian Patients
NCT01758939 ·Status: UNKNOWN
-
Use of Direct-acting Antiviral to Treat HCV Recurrence After Liver Transplantation (ANRSCO23CUPILT) Infection
NCT01944527 ·Status: UNKNOWN
-
Study of Hepatitis C Virus (HCV) Viral Kinetics in HIV/HCV and HCV Patients
NCT00703560 ·Status: COMPLETED